Business
Magnetic Nanoparticles Leap From Lab Bench to Breast Cancer Clinical Trials
Magnetic Nanoparticles Leap From Lab Bench to Breast Cancer Clinical Trials.
About this update from Manhattan Scientifics, Inc.
[{"type":"text","content":"\n \n Manhattan Scientifics, Inc. (MHTX) (OTCQB: MHTX) today issued an update \n on its affiliates' progress regarding its Early Cancer Detection \n Diagnostic\n \n \n The entire article can be read at this link:https://share-ng.sandia.gov/news/resources/news_releases/magnetic_nanoparticles/#.Wui5fKQvyiM\n \n \n Manhattan Scientifics seed funded Imagion Biosystems. MHTX invested \n eight years of development and owns 64 million shares of Imagion \n Biosystems after its public offering on the Australian stock \n exchange. (IBX.ASX)\n \n \n About Manhattan Scientifics, Inc.\n \n \n Manhattan Scientifics Inc. (www.mhtx.com) \n is located in New Mexico, New York and Montreal. It is focused on \n technology transfer and commercialization of transformative technologies.\n \n \n Forward-looking statement\n \n \n This press release contains forward-looking statements, which are \n subject to a number of risks, assumptions and uncertainties that could \n cause the Company's actual results to differ materially from those \n projected in such forward-looking statements. Management at Manhattan \n Scientifics believes that purchase of its shares should be considered to \n be at the high end of the risk spectrum. Forward-looking statements \n speak only as of the date made and are not guarantees of future \n performance. We undertake no obligation to publicly update or revise any \n forward-looking statements.\n \n \n \n View source version on businesswire.com: https://www.businesswire.com/news/home/20180502005943/en/","length":3382,"tagName":"div"}]